67
Views
1
CrossRef citations to date
0
Altmetric
Review

Do early HER2-overexpression breast cancer patients benefit from undergoing neoadjuvant trastuzumab and mastectomy? A meta-analysis

, , , , &
Pages 8043-8054 | Published online: 29 Aug 2019